Overview

A Clinical Study of ONO-1110 in Patients With Fibromyalgia

Status:
RECRUITING
Trial end date:
2026-09-01
Target enrollment:
Participant gender:
Summary
To Evaluate the Efficacy and Safety of ONO-1110 in Patients with Fibromyalgia
Phase:
PHASE2
Details
Lead Sponsor:
Ono Pharmaceutical Co. Ltd